← Back to Search

Orthokeratology

Euclid orthokeartology (enhanced coating) for Near-sightedness

N/A
Waitlist Available
Research Sponsored by Euclid Systems Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 6-35 (inclusive) and able to understand and assent to participation
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare how comfortable Euclid orthokeratology lenses are with and without a special coating in 50 children. They will also track how much the children's eyes grow in size over time.

Who is the study for?
This trial is for children who are near-sighted and have healthy corneas. They must be willing to wear orthokeratology lenses and participate in regular check-ups to monitor the length of their eyes.Check my eligibility
What is being tested?
The study compares two types of Euclid orthokeratology lenses: one with an enhanced coating and another with a standard coating, focusing on lens comfort and effectiveness in slowing down eye growth.See study design
What are the potential side effects?
Potential side effects may include discomfort while wearing the lenses, temporary visual disturbances, or minor eye irritation due to the coatings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 35 years old and can understand and agree to participate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lens wettability
Secondary outcome measures
Patient comfort ratings

Trial Design

2Treatment groups
Experimental Treatment
Group I: Euclid orthokeartology (standard coating)Experimental Treatment1 Intervention
Euclid Orthokeratology Contact Lenses are lathe cut contact lenses with spherical posterior surfaces. The posterior curve is selected to properly fit an individual eye for orthokeratology and the anterior curve is selected to provide the necessary optical power for a temporary reduction of myopia. A peripheral curve system on the posterior surface allows tear exchange between the lens and the cornea.
Group II: Euclid orthokeartology (enhanced coating)Experimental Treatment1 Intervention
Euclid Orthokeratology Contact Lenses are lathe cut contact lenses with spherical posterior surfaces. The posterior curve is selected to properly fit an individual eye for orthokeratology and the anterior curve is selected to provide the necessary optical power for a temporary reduction of myopia. A peripheral curve system on the posterior surface allows tear exchange between the lens and the cornea.

Find a Location

Who is running the clinical trial?

Euclid Systems CorporationLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial accepting participants who are younger than 70 years of age?

"Patients aged between 6 and 35 years old are sought for enrollment in this study. There exist a total of 96 clinical trials catering to minors, while there are 25 studies dedicated to elderly patients above the age of 65."

Answered by AI

In how many diverse venues is this experimental examination currently being conducted?

"Five clinical sites are currently active for this research, including the Specialty Eyecare Group in Kirkland, Cornea and Contact Lens Institute of Minnesota in Edina, and Pinecone Vision Center in Sartell. Additionally, there are five more locations participating in the study."

Answered by AI

Are there any available vacancies for patient participation in this clinical trial?

"As per clinicaltrials.gov, this specific trial is not currently seeking new participants. The initial posting date for this study was May 1st, 2024 and the most recent update occurred on April 26th, 2024. Despite the closure of recruitment for this trial, there are presently 135 alternative trials actively enrolling subjects."

Answered by AI
~33 spots leftby Aug 2025